Literature DB >> 29768057

Nocebo effects: more investigation is needed.

Fabrizio Benedetti1,2, Aziz Shaibani3.   

Abstract

Keywords:  Nocebo; clinical trials; expectation; placebo

Mesh：

Year:  2018        PMID： 29768057     DOI： 10.1080/14740338.2018.1474199

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN： 1474-0338            Impact factor:   4.250


× No keyword cloud information.
  4 in total

1.  Adverse Events and Nocebo Effects in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Christopher Ma; Nicola R Panaccione; Tran M Nguyen; Leonardo Guizzetti; Claire E Parker; Isra M Hussein; Niels Vande Casteele; Reena Khanna; Parambir S Dulai; Siddharth Singh; Brian G Feagan; Vipul Jairath
Journal:  J Crohns Colitis       Date:  2019-09-19       Impact factor: 9.071

2.  Repeated Gastric Motility Measurement Affects Gastric Motility and Epigastric Symptom Sensation.

Authors:  Nick Goelen; John F Morales; Jan Tack; Pieter Janssen
Journal:  Front Med (Lausanne)       Date:  2020-04-30

3.  Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan.

Authors:  David Kudrow; John H Krege; Hans P Hundemer; Paul H Berg; Rashna Khanna; Michael H Ossipov; Patricia Pozo-Rosich
Journal:  Headache       Date:  2020-01-13       Impact factor: 5.887

4.  Ethical issues surrounding the study of nocebo effects: Recommendations for deceptive research.

Authors:  Rebecca K Webster; John Weinman; G James Rubin
Journal:  Br J Health Psychol       Date:  2018-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.